Welcome
"Hello, I'm Luka Nicin, founder & lead consultant of NicinBio Strategy. With years of hands-on experience in biomedical research & pharmaceutical strategy consulting, I've dedicated my career to delivering expert insights and strategic guidance, empowering organizations to thrive in this complex and ever-evolving sector."
Dr. Luka Nicin, MBA
Decades of Expertise in the Pharmaceutical Industry
Meet Our Expert Panel
Strategy Consulting & Research Expertise
Experiences
BioPharma Strategy Consulting
Profound experience in R&D strategy support for
10+ EU & US based biotech & pharma clients.
Screened, evaluated, and prioritized 500+ assets &
technologies for biopharma portfolio strategy.
Highlighted projects​
Out-Licensing
Partnering support of early
immuno-oncology programs
EU biotech client
Market Dynamics
Landscape analysis for emerging technologies as ADCs & degraders
EU mid-sized pharma client
Target Search
Target identification and evaluation for novel DR-addressing technology
EU biotech client
In-Licensing
Asset search of oncology assets with transformative potential
US biopharma client
Portfolio Strategy
Positioning for development of radiopharmaceuticals
EU biotech client
Clinical Development
Strategy generation for oncological lead asset
US biotech company
Biomedical Research
Research tenures at top notch research institutions, including Goethe University Frankfurt (Dimmeler Lab) & Stanford University (Blau Lab).
Made substantial contributions to the understanding
of molecular & pediatric cardiology.
Highlighted publications
​
-
Deciphered intercellular communication patterns in the human hypertrophied heart (Nature Cardiovascular Research)
-
Found novel signatures in hearts of pediatric dilated cardiomyopathy patients (Circulation)
-
Pioneered in understanding the role of ACE2 expression in the human heart with respect to COVID-19 (European Heart Journal)
-
Reviewed the current literature regarding cellular communication pathways in the healthy & diseased heard (FEBS)
-
Elucidated novel immature & hyperplastic patterns in hearts of pediatric Rasopathy patients (JMCC)
-
Developed a 3D tissue mimetic model of the heart to study intercellular cross-talk (JMCC)
-
Co-developed an in-vitro model to study the cardiac side effects of pharmaceuticals (Anasthesia & Analgesia)
Education
Dr. med. sci.
(PhD)
Deciphered the heterogeneity & intercellular cross-talk in the failing human heart
MBA
Focused on VC financing of biotech start-ups comparing US & China
Research Internship
Research on cardiac stem cells & developed a model to assess cardiac toxicity
M.Sc.
Molecular medicine, focused on cardiovascular, oncology & immunology
B.Sc.
Biological sciences, incl. semester abroad at Charles University, Prague